ClinicalTrials.Veeva

Menu
I

Investigative Clinical Research of Indiana, LLC | Noblesville, IN

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Dexamethasone
Gemcitabine
Platinum
Sacituzumab
Pembrolizumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL w...

Enrolling
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Drug: Selinexor (continuous therapy)
Drug: Gemcitabine (combination therapy)

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surg...

Enrolling
Triple Negative Breast Cancer
Drug: Capecitabine
Drug: Sacituzumab govitecan-hziy (SG)

Trial sponsors

Gilead Sciences logo
Karyopharm Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems